Registration number:
Superpharm Bolton Ltd
for the Year Ended 31 July 2021
Superpharm Bolton Ltd
(Registration number: 09449153)
Balance Sheet as at 31 July 2021
Note |
2021 |
2020 |
|
Fixed assets |
|||
Other financial assets |
1,814,134 |
1,814,134 |
|
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets/(liabilities) |
|
( |
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
62 |
102 |
|
Share premium reserve |
583,643 |
583,643 |
|
Capital redemption reserve |
40 |
- |
|
Profit and loss account |
296,176 |
357,094 |
|
Shareholders' funds |
879,921 |
940,839 |
Superpharm Bolton Ltd
(Registration number: 09449153)
Balance Sheet as at 31 July 2021
For the financial year ending 31 July 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised by the
......................................... |
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2021
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
The financial statements have been prepared on a going concern basis.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tax
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2021
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Other financial assets (current and non-current) |
Financial assets at cost less impairment |
Total |
|
Non-current financial assets |
||
Cost or valuation |
||
At 1 August 2020 |
1,814,134 |
1,814,134 |
At 31 July 2021 |
1,814,134 |
1,814,134 |
Impairment |
||
Carrying amount |
||
At 31 July 2021 |
|
1,814,134 |
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2021
Debtors |
Note |
2021 |
2020 |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
- |
|
|
Other debtors |
|
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
Note |
2021 |
2020 |
|
Due within one year |
|||
Loans and borrowings |
|
|
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
|
- |
|
Taxation and social security |
- |
|
|
Accruals and deferred income |
|
|
|
|
|
Creditors include bank loans which are secured of £136,933 (2020 - £77,175).
Creditors: amounts falling due after more than one year
Note |
2021 |
2020 |
|
Due after one year |
|||
Loans and borrowings |
|
|
Creditors include bank loans which are secured of £1,077,273 (2020 - £855,003).
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2021
Loans and borrowings |
2021 |
2020 |
|
Non-current loans and borrowings |
||
Bank borrowings |
|
|
2021 |
2020 |
|
Current loans and borrowings |
||
Bank borrowings |
|
|
Related party transactions |
Transactions with directors |
2021 |
At 1 August 2020 |
Advances to directors |
At 31 July 2021 |
Mr I Khan |
|||
Directors Loan Account |
- |
|
|
Mr M Naheem |
|||
Directors Loan Account |
- |
|
|
Mr SS Khan |
|||
Participator Loan Account |
- |
|
|
Other transactions with directors |
During the year Mr Khalid Iqbal and Mr Khurshid UI Hassan Hussain each recieved a payment of £30,000 in relation to their termination payments.